Stereotaxis (STXS) Net Cash Flow Growth (3y) (2013 - 2026)
Stereotaxis (STXS) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 65.71% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.60% |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -339.28% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -242.00% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 78.59% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 36.96% |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 33.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.63% |
| Dec 31, 2025 | 28.65% |
| Sep 30, 2025 | 49.11% |
| Jun 30, 2025 | -28.83% |
| Mar 31, 2025 | 19.05% |
| Dec 31, 2024 | 37.36% |
| Sep 30, 2024 | -44.60% |
| Jun 30, 2024 | -335.38% |
| Mar 31, 2024 | -243.79% |
| Dec 31, 2023 | -108.17% |
| Sep 30, 2023 | -32.38% |
| Jun 30, 2023 | 2.26% |
| Mar 31, 2023 | -12.78% |
| Dec 31, 2022 | -148.65% |
| Sep 30, 2022 | -28.38% |
| Jun 30, 2022 | -44.88% |
| Mar 31, 2022 | -23.33% |
| Dec 31, 2021 | -45.87% |
| Sep 30, 2021 | -48.28% |
| Jun 30, 2021 | -53.50% |